OncoPep
Dr. Mulé serves as Executive Vice President and Associate Center Director for Translational Research at Moffitt Cancer Center.
This person is not in the org chart
This person is not in any offices
OncoPep
Through targeting multiple tumor-associated antigens with an investigational multi-peptide vaccine and a multi-tumor antigen adoptive (MTAA) T cell therapy, OncoPep’s T cell-focused technologies are designed to be used on their own or in combination with other immunotherapeutics.